Literature DB >> 16375673

Currently used antimycotics: spectrum, mode of action and resistance occurrence.

Isabelle E J A Francois1, An M Aerts, Bruno P A Cammue, Karin Thevissen.   

Abstract

The increasing incidence of fungal infections combined with the emerging problem of antifungal drug resistance have prompted investigations of the mode of action of the currently used antifungal therapeutics (antimycotics). The routinely used antimycotics can be grouped into six different classes based on their mode of action. In this review, the mode of action and antifungal spectrum of these classes are discussed, together with possible resistance development against them.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375673     DOI: 10.2174/138945005774912744

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  13 in total

1.  Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae.

Authors:  Veronika Simons; John P Morrissey; Maita Latijnhouwers; Michael Csukai; Adam Cleaver; Carol Yarrow; Anne Osbourn
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.

Authors:  Anke Burger-Kentischer; Doris Finkelmeier; Petra Keller; Jörg Bauer; Holger Eickhoff; Gerald Kleymann; Walid Abu Rayyan; Anurag Singh; Klaus Schröppel; Karin Lemuth; Karl-Heinz Wiesmüller; Steffen Rupp
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

3.  Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPC.

Authors:  Marcos S Toledo; Loriane Tagliari; Erika Suzuki; Claudinei M Silva; Anita H Straus; Helio K Takahashi
Journal:  BMC Microbiol       Date:  2010-02-15       Impact factor: 3.605

4.  Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi.

Authors:  C Borelli; M Schaller; M Niewerth; K Nocker; B Baasner; D Berg; R Tiemann; K Tietjen; B Fugmann; S Lang-Fugmann; H C Korting
Journal:  Chemotherapy       Date:  2008-06-30       Impact factor: 2.544

5.  Dysregulation of ion homeostasis by antifungal agents.

Authors:  Yongqiang Zhang; Sabina Muend; Rajini Rao
Journal:  Front Microbiol       Date:  2012-04-05       Impact factor: 5.640

6.  Antifungal proteins: More than antimicrobials?

Authors:  Nikoletta Hegedüs; Florentine Marx
Journal:  Fungal Biol Rev       Date:  2013-01       Impact factor: 4.706

7.  Identification and Sequencing of Candida krusei Aconitate Hydratase Gene Using Rapid Amplification of cDNA Ends Method and Phylogenetic Analysis.

Authors:  Roohollah Fateh; Farideh Zaini; Parivash Kordbacheh; Mehraban Falahati; Sasan Rezaie; Roshanak Daie Ghazvini; Nahid Borhani; Mahin Safara; Azam Fattahi; Ali Kanani; Shirin Farahyar; Manzar Bolhassani; Mansour Heidari
Journal:  Jundishapur J Microbiol       Date:  2015-11-21       Impact factor: 0.747

8.  Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.

Authors:  Ikechukwu Okoli; Jeffrey J Coleman; Emmanouil Tampakakis; Emmanouil Tempakakis; W Frank An; Edward Holson; Florence Wagner; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Andy Stern; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

Review 9.  Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.

Authors:  Claudia Spampinato; Darío Leonardi
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

10.  Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms.

Authors:  Takao Watamoto; Hiroshi Egusa; Takashi Sawase; Hirofumi Yatani
Journal:  Front Microbiol       Date:  2015-12-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.